Amgen to Acquire Scholar Rock for $792M
Ticker: SRRK · Form: 8-K · Filed: Jun 18, 2025 · CIK: 1727196
Sentiment: bullish
Topics: acquisition, biotech, merger
Related Tickers: AMGN
TL;DR
Amgen buying Scholar Rock for $792M cash, deal expected H2 2025.
AI Summary
Scholar Rock Holding Corp. announced on June 18, 2025, that it has entered into a definitive agreement to be acquired by Amgen Inc. for $3.75 per share in cash, totaling approximately $792 million. This transaction is expected to close in the second half of 2025, subject to customary closing conditions.
Why It Matters
This acquisition by Amgen, a major biotechnology company, could significantly impact the development and commercialization of Scholar Rock's pipeline, particularly its treatments for fibrotic diseases.
Risk Assessment
Risk Level: medium — The acquisition is subject to customary closing conditions and regulatory approvals, which could delay or prevent its completion.
Key Numbers
- $792 million — Acquisition Value (Total cash consideration for Scholar Rock)
- $3.75 — Per Share Price (Cash amount per share for Scholar Rock stockholders)
Key Players & Entities
- Scholar Rock Holding Corp. (company) — Target company
- Amgen Inc. (company) — Acquiring company
- $3.75 (dollar_amount) — Per share acquisition price
- $792 million (dollar_amount) — Total acquisition value
- June 18, 2025 (date) — Announcement date
- second half of 2025 (date) — Expected closing period
FAQ
What is the primary reason for Amgen's acquisition of Scholar Rock?
Amgen is acquiring Scholar Rock to gain access to its pipeline of innovative therapies, particularly for fibrotic diseases, and its novel approach to targeting the TGF-beta superfamily.
What is the expected timeline for the completion of the acquisition?
The transaction is expected to close in the second half of 2025.
What is the total value of the transaction?
The transaction is valued at approximately $792 million in cash.
What is the price per share offered to Scholar Rock stockholders?
Amgen has agreed to acquire Scholar Rock for $3.75 per share in cash.
Are there any specific regulatory hurdles mentioned for the acquisition?
The filing mentions that the transaction is subject to customary closing conditions, which would include regulatory approvals.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 18, 2025 regarding Scholar Rock Holding Corp (SRRK).